BOSTON SCIENTIFIC CORP — Director's Dealing 2018

Jan 3, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-01-01

Reporting Person: Pierce David A (SVP and President, Endoscopy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-01	Common Stock	M	13341.0000	$0.0000	Acquired	37542.0000	Direct
2018-01-01	Common Stock	F	4578.0000	$24.7900	Disposed	32964.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-01	Performance Share Units	$	M	13341.0000	Disposed	2017-12-31	Common Stock (13341.0000)	Direct

Footnotes

F1: On February 23, 2015, the reporting person was awarded a target number of performance share units under the Company's 2015 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2015 adjusted free cash flow measured against its 2015 financial plan over the one-year performance period ending December 31, 2015 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2016, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2017.

F2: Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock.